Voya Investment Management LLC Deciphera Pharmaceuticals, Inc. Transaction History

Voya Investment Management LLC

$79.9 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$13.58 - $17.36 $47,855 - $61,176	-3,524 Reduced 4.93%	67,993 $1.07 Million
Q4 2023 Feb 14, 2024	BUY	$10.11 - $16.54 $507,178 - $829,745	50,166 Added 234.96%	71,517 $1.15 Million
Q3 2023 Nov 14, 2023	BUY	$12.46 - $15.48 $5,270 - $6,548	423 Added 2.02%	21,351 $271,000
Q2 2023 Aug 14, 2023	BUY	$13.28 - $15.96 $29,136 - $35,016	2,194 Added 11.71%	20,928 $294,000
Q1 2023 May 15, 2023	BUY	$14.26 - $22.1 $20,377 - $31,580	1,429 Added 8.26%	18,734 $289,000
Q2 2022 Aug 15, 2022	BUY	$9.11 - $13.98 $8,563 - $13,141	940 Added 5.74%	17,305 $228,000
Q1 2022 May 16, 2022	BUY	$6.87 - $11.11 $13,286 - $21,486	1,934 Added 13.4%	16,365 $151,000
Q4 2021 Feb 14, 2022	SELL	$7.7 - $37.13 $43,951 - $211,938	-5,708 Reduced 28.34%	14,431 $141,000
Q3 2021 Nov 15, 2021	BUY	$26.46 - $37.15 $3,148 - $4,420	119 Added 0.59%	20,139 $685,000
Q2 2021 Aug 16, 2021	SELL	$32.73 - $47.95 $7,920 - $11,603	-242 Reduced 1.19%	20,020 $733,000
Q1 2021 May 17, 2021	BUY	$40.39 - $56.73 $61,594 - $86,513	1,525 Added 8.14%	20,262 $909,000
Q4 2020 Feb 16, 2021	BUY	$51.77 - $66.18 $200,815 - $256,712	3,879 Added 26.11%	18,737 $1.07 Million
Q3 2020 Nov 16, 2020	BUY	$43.8 - $58.16 $84,884 - $112,714	1,938 Added 15.0%	14,858 $762,000
Q2 2020 Aug 14, 2020	BUY	$37.05 - $65.03 $97,145 - $170,508	2,622 Added 25.46%	12,920 $772,000
Q1 2020 May 15, 2020	BUY	$33.63 - $69.4 $22,599 - $46,636	672 Added 6.98%	10,298 $424,000
Q4 2019 Feb 14, 2020	BUY	$31.7 - $69.93 $85,685 - $189,020	2,703 Added 39.04%	9,626 $599,000
Q3 2019 Nov 14, 2019	BUY	$19.95 - $38.85 $138,113 - $268,958	6,923 New	6,923 $235,000

Others Institutions Holding DCPH

# of Institutions

Shares Held

293K

Call Options Held

500

Put Options Held

View Full List

About Deciphera Pharmaceuticals, Inc.

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

More about DCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account